Xari S 250mg/125mg Injection
Marketer
H & Care Incorp
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Xari S 250mg/125mg Injection
Combiflox 250mg/125mg Injection is a dual-action antibiotic prescribed for diverse bacterial infections. Its mechanism combats microbial proliferation, halting infection spread. Administration must be under a physician's direct guidance; strict adherence to the prescribed dosage schedule is vital. Complete the entire treatment course, regardless of symptom improvement; premature cessation may compromise its efficacy. Commonly reported side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe or persistent side effects necessitate immediate medical attention. Seek immediate medical help for any allergic reaction (e.g., rash, pruritus, edema, dyspnea). Inform your doctor of all current medications, including those for pre-existing conditions. Pregnant or lactating individuals require physician consultation prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, avoid operation of vehicles if drowsiness or dizziness occurs. Adequate rest, a balanced diet, and sufficient hydration contribute to faster recovery. Your physician may order blood tests and other assessments to monitor treatment response.
Primary Ingredients of Xari S 250mg/125mg Injection
No text was provided. Please provide the text you wish me to rephrase.
Uses of Xari S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Xari S 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Xari S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Xari S 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Xari S 250mg/125mg Injection works:
Xari S Injection, containing 250mg Ceftriaxone and 125mg Sulbactam, utilizes a dual-action approach to combat bacterial infections. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to reproduce and survive. The added Sulbactam, a beta-lactamase inhibitor, safeguards Ceftriaxone's effectiveness by neutralizing enzymes that bacteria use to develop resistance.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Xari S 250mg/125mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Xari S, 250mg/125mg, is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or absent harm to the fetus; nonetheless, data from human clinical trials remain scarce.
Breast feedingCAUTION
The administration of Xari S 250mg/125mg Injection to breastfeeding mothers requires careful consideration. It's advisable to discontinue breastfeeding throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
The administration of Xari S 250mg/125mg Injection can induce drowsiness, blurred vision, and dizziness. Driving should be avoided if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Xari S 250mg/125mg Injection to individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should receive Xari S 250mg/125mg Injection with close monitoring; dosage modification may be necessary. For patients with mild to moderate liver dysfunction, altering the Xari S 250mg/125mg Injection dose is not advised. Physician consultation is recommended.
What if you forget to take Xari S 250mg/125mg Injection :
Should you forget a scheduled dose of Xari S 250mg/125mg Injection, seek medical advice.
Facts to Know About Xari S 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently